Sodium Polystyrene Sulfonate NDC 10702-036

NDC codes

FDA NDC Directory

Product NDC (as listed)10702-036Labeler and product segments. Claims need a package NDC.

Product NDC at billing width10702-0036Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
10702-036-15	10702003615	15 g in 1 BOTTLE (10702-036-15)Marketed from Apr 3, 2015
10702-036-45	10702003645	454 g in 1 JAR (10702-036-45)Marketed from Jul 25, 2012

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sodium Polystyrene Sulfonate
Generic name (nonproprietary): sodium polystyrene sulfonate
Active ingredients: Sodium polystyrene sulfonate — 1 g/g
Dosage form: Powder
Route: Oral, Rectal
Labeler: KVK-Tech, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 040905
Marketing start: Jul 25, 2012
Listing expires: Dec 31, 2026
Identifiers: Product ID 10702-036_1213e349-d5ef-2221-e063-6294a90a8e83SPL ID 1213e349-d5ef-2221-e063-6294a90a8e83SPL set ID 905c3ee5-d1a7-4deb-a345-4a42296704faRxCUI 2101899UNII 1699G8679ZUPC 0310702036451

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N410702003615 followed by a unit qualifier and the quantity

Package 10702-0036-15. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 23, 2024.

Indications (excerpt from the label)

Sodium polystyrene sulfonate is indicated for the treatment of hyperkalemia. Limitation of Use : Sodium polystyrene sulfonate should not be used as an emergency treatment for life-threatening hyperkalemia because of its delayed onset of action [see Clinical Pharmacology (12.2)]. Sodium polystyrene sulfonate is a potassium binder indicated for the treatment of hyperkalemia. Limitation of Use : Sodium polystyrene sulfonate should not be used as an emergency treatment for life-threatening hyperkalemia because of its delayed onset of action.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)